About Semler Scientific, Inc. - Common Stock (SMLR)
Semler Scientific is a healthcare technology company that specializes in developing innovative solutions to enhance the efficiency and accuracy of diagnostic and measurement processes in medical settings. The company focuses on creating proprietary products that allow healthcare providers to assess patients more effectively, particularly in relation to cardiovascular and respiratory health. By leveraging advanced technology and data analytics, Semler aims to improve patient outcomes and streamline interactions between healthcare professionals and patients, ultimately contributing to better overall healthcare delivery. Read More
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of investors who purchased Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”). Semler investors have until October 28, 2025 to file a lead plaintiff motion.
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”). Semler investors have until October 28, 2025 to file a lead plaintiff motion.
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ:SMLR) securities during the period of March 10, 2021 through April 15, 2025, inclusive (“the Class Period”).
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025. Semler Scientific describes itself as a company that develops and markets technology products and services that assist its customers in evaluating and treating chronic diseases.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”). Semler investors have until October 28, 2025 to file a lead plaintiff motion.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Semler Scientific To Contact Him Directly To Discuss Their Options
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Semler Scientific, Inc. (“Semler” or “the Company”) (NASDAQ: SMLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Semler Scientific investors under the federal securities laws.
The financial markets are currently presenting a fascinating dichotomy, with traditional and nascent indicators painting a complex picture of economic sentiment. While equity markets often dominate headlines, the subtle movements in the bond market and the volatile ascent of cryptocurrency are providing crucial insights into broader investor behavior and economic
The financial world is witnessing a seismic shift as institutional investors increasingly embrace digital assets, moving them from the fringes of speculative investment to a core component of diversified portfolios. This accelerating adoption, underscored by recent surveys and the active involvement of financial behemoths, signals a profound transformation in how
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Semler (SMLR), GoHealth (GOCO), or Cleveland-Cliffs (CLF) To Contact Him Directly To Discuss Their Options
